38,327 Results

Surufatinib in advanced neuroendocrine tumors – extra-pancreatic,met the primary endpoint of progression free survival- Hutchinson China MediTech.

 Added 1 day ago

Hutchison China MediTech announced that the independent Data Monitoring Committee of the Phase III pivotal study of surufatinib in advanced...

Phase IIIb DIALIZE trial results of Lokelma for hyperkalaemia in patients with end-stage renal disease on haemodialysis.- AstraZeneca

 Added 1 day ago

AstraZeneca presented positive results from the Phase IIIb DIALIZE trial which investigated the efficacy and safety of Lokelma (sodium zirconium...

bluebird bio announced new data from patients in Group C of its ongoing Phase I/II HGB-206 study of LentiGlobin for sickle cell disease (SCD) at the 24th European Hematology Association (EHA) Congress.

 Added 1 day ago

bluebird bio announced new data from patients in Group C of its ongoing Phase I/II HGB-206 study of the company’s...

Phase III HOPE Study of GBT 440 met primary endpoint in sickle cell disease.- Global Blood Therapeutics

 Added 1 day ago

Global Blood Therapeutics announced new results from its Phase III HOPE Study of GBT 440 (voxelotor) in patients ages 12...

FDA approves Kanjinti for breast cancer and gastric cancer.- Amgen + Allergan

 Added 1 day ago

Amgen and Allergan plc announced that the FDA has approved Kanjinti (trastuzumab-anns) for all approved indications of the reference product,...

NORTHSTAR-2 and 3 phase III trials of Lentiglobin show efficacy to month 16 in beta-thalassemia.- bluebird bio

 Added 1 day ago

bluebird bio announced new data from the Phase III Northstar-2 (HGB-207) and Phase III Northstar-3 (HGB-212) clinical studies of its...

Positive results for Taltz vs. Humira in a head-to-head (SPIRIT-H2H) superiority study in active psoriatic arthritis. - Eli Lilly

 Added 1 day ago

Eli Lilly and Company announced that the company will present positive findings from the Phase IIIb/IV SPIRIT-Head-to-Head (H2H) study in...

Novartis reports long-term data from the ENESTfreedom and ENESTop trials of Tasigna for Ph+ chronic myeloid leukemia.

 Added 1 day ago

Long-term follow-up data from the ongoing, pivotal open-label ENESTfreedom and ENESTop trials showed sustained treatment-free remission (TFR) after stopping frontline...

EULAR 2019 | SUICIDAL THOUGHTS RELATED TO PAIN IN ONE IN TEN PATIENTS WITH RHEUMATIC OR MUSCULOSKELETAL DISEASE

 Added 2 days ago

Huge impact of pain and sleep on mental health raises questions about the level of care offered to patients1

EULAR 2019 | STUDY REVEALS SIGNIFICANT GAPS IN ESSENTIAL RHEUMATOID ARTHRITIS CARE ACROSS EUROPE AND BETWEEN EUROPEAN COUNTRIES

 Added 2 days ago

Over half of patients and rheumatologists report diagnosis within six weeks as the most problematic standard of care1

Load more